EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 13-Oct-2025 03:12 ET (13-Oct-2025 07:12 GMT/UTC)

9-Sep-2025

Predicting where deadly brain cancer may spread next

Researchers at the Fralin Biomedical Research Institute at VTC have developed a method that uses MRI and fluid dynamics to predict where glioblastoma may return. By tracking how fluid moves through and around the tumor, their algorithm identifies hidden cancer cells and highlights invasion pathways so surgeons can target them more precisely.

Journal: npj Biomedical Innovations
Funder: NIH/National Cancer Institute, NIH/National Institute of Neurological Disorders and Stroke, Red Gates Foundation, American Cancer Society

9-Sep-2025

“Bottlebrush” particles deliver big chemotherapy payloads directly to cancer cells

Massachusetts Institute of Technology
Peer-Reviewed Publication

Using nanoparticles shaped like bottlebrushes, MIT chemists can deliver a large range of chemotherapy drugs directly to tumor cells, which could reduce the side effects of treatment.

Journal: Nature Biotechnology
Funder: NIH/National Institutes of Health, Ludwig Center at MIT, Koch Institute Frontier Research Program

9-Sep-2025

Circulating tumor DNA may guide immunotherapy use in limited-stage SCLC, new study shows

International Association for the Study of Lung Cancer
Reports and Proceedings

A new study presented at the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer (WCLC) demonstrates that monitoring circulating tumor DNA (ctDNA) can refine and personalize the use of consolidation immunotherapy in patients with limited-stage small cell lung cancer (LS-SCLC).

9-Sep-2025

Novel immunotherapy strategy shows promising long-term survival in advanced NSCLC patients with inadequate response to immune checkpoint inhibitors

International Association for the Study of Lung Cancer
Reports and Proceedings

A new study presented today reports encouraging long-term survival outcomes from an experimental viral immunotherapy, CAN-2409, in patients with advanced non-small cell lung cancer (NSCLC) who previously failed to respond adequately to immune checkpoint inhibitors (ICI).The study was presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer.

9-Sep-2025

Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC

International Association for the Study of Lung Cancer
Reports and Proceedings

A randomized Phase II trial from National Taiwan University Hospital reports early evidence that resecting the primary thoracic tumor following EGFR tyrosine kinase inhibitor (TKI) therapy may prolong disease control in patients with metastatic EGFR-mutated non-small cell lung cancer (NSCLC). The study was presented today at the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer (WCLC).

9-Sep-2025

Lung Cancer Europe study highlights communication gaps and need for shared decision-making

International Association for the Study of Lung Cancer
Reports and Proceedings

A large-scale survey conducted by Lung Cancer Europe (LuCE) has identified critical communication barriers that affect information access, understanding, and shared decision-making among lung cancer patients and caregivers across Europe. The research was reported at the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer (WCLC).

9-Sep-2025

FANSS study demonstrates feasibility of U.S.-based lung cancer screening in Asian female nonsmokers

International Association for the Study of Lung Cancer
Reports and Proceedings

Results from the Female Asian Nonsmoker Screening Study (FANSS) highlight the potential value of low-dose CT (LDCT) screening for lung cancer among a growing but underserved population: Asian women with no history of smoking. The study results were reported today at the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer (WCLC).

8-Sep-2025

Study used AI models to improve prediction of chronic kidney disease progression to end stage renal disease

Carnegie Mellon University
Peer-Reviewed Publication

In a new study, researchers used machine learning and deep learning models, as well as explainable artificial intelligence (AI), to assess integrated clinical and claims data with the goal of improving prediction of CKD’s progression to ESRD. The integrated models outperformed single data source models, which can enhance CKD management, support targeted interventions, and reduce health-care disparities.

8-Sep-2025

Compact genetic light switches transform disease control

Texas A&M University
Peer-Reviewed Publication

Researchers have created new light-controlled tools that respond to blue light with pinpoint accuracy, offering safer, more precise treatments in the future.

Journal: Nature Communications
Funder: NIH/National Institutes of Health, Welch Foundation, Cancer Prevention and Research Institute of Texas, Alkek Early Career Fellowship, Leukemia and Lymphoma Society

8-Sep-2025

Lung cancer genetics study launches open-source data platform to research community

23andMe Research Institute
Business Announcement

At the 2025 World Conference on Lung Cancer in Barcelona, the 23andMe Research Institute, in collaboration with Troper Wojcicki Philanthropies and the health data software company Lifebit, introduced an open source platform that could help fast-track research discoveries through a powerful new cancer data repository. Access to this powerful new tool is FREE to qualified researchers.